Effects of transforming growth factor‑β1 on the proliferation and invasion of the HTR‑8/SVneo cell line

Zuo,Yanzhen; Fu,Zhihua; Hu,Yatao; Li,Yuhong; Xu,Qian; Sun,Dayong; Tan,Yusi

doi:10.3892/ol.2014.2451

Effects of transforming growth factor‑β1 on the proliferation and invasion of the HTR‑8/SVneo cell line

Authors:
- Yanzhen Zuo
- Zhihua Fu
- Yatao Hu
- Yuhong Li
- Qian Xu
- Dayong Sun
- Yusi Tan
View Affiliations

Affiliations: Department of Pharmacology, Chengde Medical University, Chengde, Hebei 067000, P.R. China, Department of Nursing, Chengde Nursing Vocational College, Chengde, Hebei 067000, P.R. China, Department of Pathophysiology, Chengde Medical University, Chengde, Hebei 067000, P.R. China, Department of Research Laboratory, Chengde Medical University, Chengde, Hebei 067000, P.R. China, Department of Tumor Radiation and Chemotherapy Center, Chengde Central Hospital, Chengde, Hebei 067000, P.R. China
Published online on: August 18, 2014 https://doi.org/10.3892/ol.2014.2451
Pages: 2187-2192

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Transforming growth factor‑β1 (TGF‑β1) is involved in the regulation of trophoblast cell proliferation and invasion. However, the mechanism underlying this process remains unknown, which is predominantly due to the difficulty in obtaining and maintaining primary trophoblast cells in culture over a long period of time. The HTR‑8/SVneo cell line is an immortalized trophoblast cell line, which has been reported to exhibit a number of similar characteristics to those of parental trophoblast cells. Therefore, the cell line has been a useful tool for the investigation of placental function and tumor progression. In the present study, the HTR‑8/SVneo cell line was used as a model to investigate the TGF‑β1/SMAD signaling pathway in the proliferation and invasion of trophoblast cells. The proliferation and invasion ability of HTR‑8/SVneo cells was determined using the MTT and Transwell assays, respectively. In addition, reverse transcription polymerase chain reactions were performed to detect the mRNA expression of a panel of known downstream mediators of TGF‑β1, including TGF‑β receptor I (TβRI), SMAD4, SMAD3, SMAD7 and tissue inhibitor of metalloproteinases‑1 (TIMP‑1). The results indicated that TGF‑β1 promotes the proliferation and invasion of the HTR‑8/SVneo cell line at passage 90. Furthermore, the expression of TβRI, SMAD3 and SMAD4 were reduced following treatment with TGF‑β1, while the expression of SMAD7 was increased and the expression of TIMP‑1 remained unchanged following TGF‑β1 treatment. These observations indicated that the effects of TGF‑β1 on the proliferation and invasion of the HTR‑8/SVneo cell line at passage 90 were different from those of parental trophoblasts, which is in contrast to the results of previous studies. It was concluded that the HTR‑8/SVneo cell lines, which have been grown for over 90 passages, do not accurately represent parental trophoblast cells in studies of the TGF‑β/SMAD signaling pathway.

View Figures

View References

1	Prossler J, Chen Q, Chamley L and James JL: The relationship between TGFβ, low oxygen and the outgrowth of extravillous trophoblasts from anchoring villi during the first trimester of pregnancy. Cytokine. 68:9–15. 2014.
2	Genest DR, Berkowitz RS and Fisher RA: Gestational trophoblastic disease. World Health Organization Classification of Tumours, Pathology and Genetics Tumours of the Breast and Female Genital Organs. Tavassoli FA and Devilee P: 4. 3rd edition. IARC Press; Lyon: pp. 250–254. 2003
3	Knöfler M: Critical growth factors and signalling pathways controlling human trophoblast invasion. Int J Dev Biol. 54:269–280. 2010.
4	Lunghi L, Ferretti ME, Medici S, et al: Control of human trophoblast function. Reprod Biol Endocrinol. 5:62007.
5	Simpson H, Robson SC, Bulmer JN, et al: Transforming growth factor beta expression in human placenta and placental bed during early pregnancy. Placenta. 23:44–58. 2002.
6	Graham CH, Lysiak JJ, McCrae KR and Lala PK: Localization of transforming growth factor-beta at the human fetal-maternal interface: role in trophoblast growth and differentiation. Biol Reprod. 46:561–572. 1992.
7	Lysiak JJ, Hunt J, Pringle GA and Lala PK: Location of transformationg growth factor beta and its natural inhibitor decorin in the human placenta and deciduas throughout gestation. Placenta. 16:221–231. 1995.
8	Graham CH and Lala PK: Mechanism of control of trophoblast invasion in situ. J Cell Physiol. 148:228–234. 1991.
9	Zhen FA, Ying-Yong L, Guang CY and Jun LY: Effect and significance of TGF-β1 on cell proliferation of human first trimester cytotrophoblasts and JAR cells. MCHCC. 18:2582–2585. 2008.(In Chinese).
10	Lala PK and Chakraborty C: Factors regulating trophoblast migration and invasiveness: possible derangements contributing to pre-eclampsia and fetal injury. Placenta. 24:575–587. 2003.
11	Zhao MR, Qiu W, Li YX, et al: Dual effect of transforming growth factor beta1 on cell adhesion and invasion in human placenta trophoblast cells. Reproduction. 132:333–341. 2006.
12	Graham CH, Hawley TS, Hawley RG, et al: Establishment and characterization of first trimester human trophoblast cells with extended lifespan. Exp Cell Res. 206:204–211. 1993.
13	Shi Y and Massagué J: Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell. 113:685–700. 2003.
14	Kaminska B, Kocyk M and Kijewska M: TGF beta signaling and its role in glioma pathogenesis. Adv Exp Med Biol. 986:171–187. 2013.
15	Petroff MG, Phillips TA, Ka H, et al: Isolation and culture of term human trophoblast cells. Methods Mol Med. 121:203–217. 2006.
16	Suzuki T, Higgins PJ and Crawford DR: Control selection for RNA quantitation. Biotechniques. 29:332–337. 2000.
17	Sundqvist A, Ten Dijke P and van Dam H: Key signaling nodes in mammary gland development and cancer: Smad signal integration in epithelial cell plasticity. Breast Cancer Res. 14:2042012.
18	Collet C, Laplanche JL and de Vernejoul MC: Camurati-Engelmann disease with obesity in a newly identified family carrying a missense p.Arg156Cys mutation in the TGFB1 gene. Am J Med Genet A. 161A:2074–2077. 2013.
19	Lv ZD, Kong B, Li JG, et al: Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Oncol Rep. 29:219–225. 2013.
20	Lee D, Chung YH, Kim JA, et al: Transforming growth factor beta 1 overexpression is closely related to invasiveness of hepatocellular carcinoma. Oncology. 82:11–18. 2012.
21	Dave H, Shah M, Trivedi S and Shukla S: Prognostic utility of circulating transforming growth factor beta 1 in breast cancer patients. Int J Biol Markers. 27:53–59. 2012.
22	Dehaghani AS, Rad NR, Fattahi MJ, et al: Investigation of soluble HER2 and transforming growth factor Beta-1 serum levels in gestational trophoblastic disease. Pathol Oncol Res. 15:37–40. 2009.
23	Khoo NK, Bechberger JF, Shepherd T, et al: SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. I. Mechanisms responsible for hyperinvasiveness and resistance to anti-invasive action of TGFbeta. Int J Cancer. 77:429–439. 1998.
24	Khoo NK, Zhang Y, Bechberger JF, Bond SL, Hum K and Lala PK: SV40 Tag transformation of the normal invasive trophoblast results in a premalignant phenotype. II. Changes in gap junctional intercellular communication. Int J Cancer. 77:440–448. 1998.
25	Guo RF, Zang SZ, Zhang L, et al: Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer. Zhonghua Yi Xue Za Zhi. 86:3249–3254. 2006.(In Chinese).
26	Huang CH, Tseng WY, Yao CC, et al: Glucosamine promotes osteogenic differentiation of dental pulp stem cells through modulating the level of the transforming growth factor-beta type I receptor. J Cell Physiol. 225:140–151. 2010.
27	Chegini N, Luo X, Ding L and Ripley D: The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol. 209:9–16. 2003.
28	Yang G and Yang X: Smad4-mediated TGF-beta signaling in tumorigenesis. Int J Biol Sci. 6:1–8. 2010.
29	Brown KA, Pietenpol JA and Moses HL: A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem. 101:9–33. 2007.
30	Leng A, Liu T, He Y, et al: Smad4/Smad7 balance: a role of tumorigenesis in gastric cancer. Exp Mol Pathol. 87:48–53. 2009.
31	Chen QX, Shao BY, Zheng H, et al: Expression and significance of TGF-B1 and its intracellular signaling molecules SMAD4, SMAD7 in human glioma. Chin J Exp Surg. 1:90–92. 2005.
32	Lu B, Zhou YN, Li Q, et al: Correlations of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic characteristics and prognosis of gastric cancer. Ai Zheng. 28:538–542. 2009.
33	Schiller M, Javelaud D and Mauviel A: TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. J Dermatol Sci. 35:83–92. 2004.
34	Mori Y, Chen SJ and Varga J: Modulation of endogenous Smad expression in normal skin fibroblasts by transforming growth factor-beta. Exp Cell Res. 258:374–383. 2000.
35	Nakao A, Okumura K and Ogawa H: Smad7: a new key player in TGF-beta-associated disease. Trends Mol Med. 8:361–363. 2002.
36	Kleeff J, Ishiwata T, Maruyama H, et al: The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene. 18:5363–5372. 1999.
37	Huo YY, Zhang KT, Li BY, et al: Regulation of Smad7 gene by TGF-beta 1 in the process of malignant transformation. Ai Zheng. 21:117–121. 2002.(In Chinese).
38	Bischof P, Meisser A and Campana A: Paracrine and autocrine regulators of trophoblast invasion - a review. Placenta. 21(Suppl A): S55–S60. 2000.
39	Burns JS, Abdallah BM, Guldberg P, et al: Tumorigenic heterogeneity in cancer stem cells evolved form long-term cultures of telomerase-immortalized human mesenchymal stem cells. Cancer Res. 65:3126–3135. 2005.
40	Hai C, Jun D, Xi-Chuan Y, et al: Genetic stability of immortal melanocytes transfected by SV40T antigen gene [J]. Practical Journal of Clinical Medicine. 5:24–27. 2008.
41	Ahuja D, Sáenz-Robles MT and Pipas JM: SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene. 24:7729–7745. 2005.
42	Bosticardo M, Ghosh A, Du Y, et al: Self-inactivating retroviral vector-mediated gene transfer induces oncogene activation and immortalization of primary murine bone marrow cells. Mol Ther. 17:1910–1918. 2009.